Abhinav Acharya

Arizona State University-Tempe Campus

$3,362,178

Attributed

$3,362,178

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $711K · FY2021–25

$1M$750K$500K$250K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,362,178 · 2

By mechanism

R01$3,362,178 · 2

Top collaborators

No co-investigators on record.

Most similar at Arizona State University-Tempe Campus

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Glycolysis Inhibition”

Pinelopi P. Kapitsinou · University Of Kansas Medical Center$3,632,107
Pavithra Viswanath · University Of California, San Francisco$3,496,515
Claudio Scafoglio · University Of California Los Angeles$2,825,956
Vlad C Sandulache · Baylor College Of Medicine$2,676,047
Angelo D'alessandro · University Of Colorado Denver$2,639,727
Krishna C Penumatsa · Tufts Medical Center$2,572,205

Research focus

Glycolysis InhibitionKidneyExtracellularGlycolysisImmunohistochemistryIn VivoDendritic Cell ActivationExperimental StudyFrequenciesGenus HippocampusHelper-Inducer T-LymphocyteImmuneAppropriate DoseIn VitroCellsCitric Acid CycleDendritic CellsDoseFormulationBiocompatible MaterialsAntigen-Presenting CellsFutureAntigensKinetics